Increased Risk of Dermatomyositis in Patients with Psoriasis: A Retrospective Cohort Study
This study revealed a higher risk of dermatomyositis in patients with psoriasis than in those without. The psoriatic patients with PsA or those who had received IL-17i treatment demonstrated a significantly higher risk of developing dermatomyositis.
Authors
- Sheng‐Ming Dai (ORCID: https://orcid.org/0000-0001-8876-4205)
- Hua Zhang (ORCID: https://orcid.org/0000-0001-6821-4492)
- James Cheng‐Chung Wei (ORCID: https://orcid.org/0000-0002-1235-0679)
- Na Tian (ORCID: https://orcid.org/0000-0001-5627-5095)
- Qian Wang (ORCID: https://orcid.org/0000-0002-2940-1858)
- Qiang Tong (ORCID: https://orcid.org/0000-0002-4692-9363)
- Zhiyong Chen (ORCID: https://orcid.org/0000-0001-6766-0503)
- Ran Cui (ORCID: https://orcid.org/0000-0003-3328-0160)
- Miao Chen (ORCID: https://orcid.org/0000-0003-2579-7741)
- Yu-Hsun Wang
Institutions
- Shanxi Medical University (CN)
- Shanghai Jiao Tong University (CN)
- China Medical University (TW)
- Chung Shan Medical University Hospital (TW)
- Shanghai Sixth People's Hospital (CN)
- Shanxi Academy of Medical Sciences (CN)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- ImmunoTargets and Therapy
- Published
- 2025-02-28
- DOI
- https://doi.org/10.2147/itt.s500811
- Citations
- 2
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 2.71